Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

Detalles Bibliográficos
Autores principales: Iketani, Sho, Forouhar, Farhad, Liu, Hengrui, Hong, Seo Jung, Lin, Fang-Yu, Nair, Manoj S., Zask, Arie, Huang, Yaoxing, Xing, Li, Stockwell, Brent R., Chavez, Alejandro, Ho, David D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098641/
https://www.ncbi.nlm.nih.gov/pubmed/33953192
http://dx.doi.org/10.1038/s41467-021-23082-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098641/
https://www.ncbi.nlm.nih.gov/pubmed/33953192
http://dx.doi.org/10.1038/s41467-021-23082-3

Ejemplares similares